Neurological care without borders, gaps, or guesswork.
Quantalcare builds accessible solutions for Parkinson's — clinical software for providers, objective symptom tracking, and proven medicines and therapeutics — for the regions where care is hardest to reach. Starting in India.
Where you live still decides the care you get.
Parkinson's affects people everywhere. The tools to manage it don't reach everywhere. Our work is to close that gap — for Parkinson's first, and for other neurological conditions as we grow.
Formulations that are standard of care in one region are unavailable in another — not because they don't work, but because nobody has brought them there.
Symptom-tracking apps and wearable software launch in a handful of markets and leave the rest waiting, including the regions with the most patients per neurologist.
The latest research on therapeutics and symptom management lives in specialist centers and journals — far from the providers making day-to-day decisions.
Three ways to make Parkinson's care accessible.
We design and build clinical applications alongside leading researchers — including tools that put current evidence on therapeutics and suggested care for non-motor symptoms of Parkinson's directly in providers' hands.
- Built with researchers, for the point of care
- Covers the symptoms hardest to manage, including non-motor
- Updated as the evidence evolves
A watch app in development that passively measures Parkinson's symptoms through the day, so patients and clinicians can ground care decisions in longitudinal data rather than recall.
- Passive capture from a watch patients already wear
- Objective, longitudinal metrics — not diaries
- Built to be available where it's needed, not region-locked
We work to bring established medicines and evidence-backed therapeutics to India — formulations and treatments that patients elsewhere already rely on, but that aren't yet available locally.
- Easier-to-take formulations of standard Parkinson's medication
- Evidence-backed gut-health therapeutics studied in Parkinson's
- India first, expanding to other underserved regions
We're just getting started.
Today our work centers on Parkinson's care in India. Here is where it goes next.
The same tools, medicines, and therapeutics, brought to more regions where access to Parkinson's care is limited.
More medicines, more therapeutics, and more clinical software — added as evidence and partnerships mature.
Extending what we build to other neurological conditions, applying what we learn in Parkinson's care.
Working in one of these areas already? We'd like to hear from you before we get there.
Working on neurological care access? Let's talk.
We partner with clinicians, researchers, health systems, and manufacturers who want their work to reach more patients.